Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ombretta Turriziani

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Journal of Medical Virology|September 13, 2022
Detection of SARS-CoV-2 RNA and antibodies in breast milk of infected mothersMarianna Calabretto, Rossella D'Alisa, Sara Faraone, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
Cellular issues relating to the resistance of HIV to antiretroviral agentsOmbretta Turriziani, Carolina Scagnolari, Francesca Bellomi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 24, 2016
Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patientsIlaria Vicenti, Francesca Falasca, Laura Sticchi, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patientsOmbretta Turriziani, Nicola Gianotti, Federica Bambacioni, et al.
Andrology|May 27, 2020
SARS-CoV-2 presence in seminal fluid: Myth or realityDonatella Paoli, Francesco Pallotti, Ombretta Turriziani, et al.
Antiviral Therapy|September 6, 2002
Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudineOmbretta Turriziani, Carolina Scagnolari, Federica Bambacioni, et al.
The New Microbiologica|October 21, 2015
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimizationAlessandra Fantauzzi, Marco Floridia, Francesca Falasca, et al.
The New Microbiologica|June 11, 2016
Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremiaLaura Mazzuti, Maria Antonietta Lozzi, Elisabetta Riva, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 30, 2020
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?Francesca Falasca, Ilaria Sciandra, Daniele Di Carlo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 16, 2015
Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimenFrancesca Falasca, Laura Mazzuti, Gabriella DʼEttorre, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Journal of Medical Virology|September 13, 2022
Detection of SARS-CoV-2 RNA and antibodies in breast milk of infected mothersMarianna Calabretto, Rossella D'Alisa, Sara Faraone, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|March 6, 2004
Cellular issues relating to the resistance of HIV to antiretroviral agentsOmbretta Turriziani, Carolina Scagnolari, Francesca Bellomi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 24, 2016
Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patientsIlaria Vicenti, Francesca Falasca, Laura Sticchi, et al.
AIDS Research and Human Retroviruses|August 17, 2004
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patientsOmbretta Turriziani, Nicola Gianotti, Federica Bambacioni, et al.
Andrology|May 27, 2020
SARS-CoV-2 presence in seminal fluid: Myth or realityDonatella Paoli, Francesco Pallotti, Ombretta Turriziani, et al.
Antiviral Therapy|September 6, 2002
Selection of a T-cell line resistant to stavudine and zidovudine by prolonged treatment with stavudineOmbretta Turriziani, Carolina Scagnolari, Federica Bambacioni, et al.
The New Microbiologica|October 21, 2015
Backbone switch to abacavir/lamivudine fixed-dose combination: implications for antiretroviral therapy optimizationAlessandra Fantauzzi, Marco Floridia, Francesca Falasca, et al.
The New Microbiologica|June 11, 2016
Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremiaLaura Mazzuti, Maria Antonietta Lozzi, Elisabetta Riva, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 30, 2020
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?Francesca Falasca, Ilaria Sciandra, Daniele Di Carlo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 16, 2015
Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimenFrancesca Falasca, Laura Mazzuti, Gabriella DʼEttorre, et al.
Pageof 12